Obesity and gallbladder disease

Handbook of Obesity: Etiology and Pathophysiology, Second Edition

Volumn , Issue , 2003, Pages 919-934

  Ko, Cynthia W ^a   Lee, Sum P ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2942664466     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (168)

1. Scharschmidt BF. Bilirubin metabolism, bile formation, and gallbladder and bile duct function. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. Philadelphia: W.B. Saunders, 1993:1730–1746.
2. Cooper AD. Epidemiology, pathogenesis, natural history, and medical therapy of gallstones. In: Sleisinger MH, Fordtran JS, eds. Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. Philadelphia: W.B. Saunders, 1993:1788–1804.
3. Somjen GJ, Gilat T. A non-micellar mode of cholesterol transport in human bile. FEBS Lett 1983; 156:265–268.
4. Cohen DE, Ranginani N, Vanpatten S, Rossetti L. Leptin regulates coupling of biliary cholesterol to bile salt secretion in Zucker rats [abstract]. Hepatology 1999; 30:429A.
5. Duggirala R, Mitchell BD, Blangero J, Stern MP. Genetic determinants of variation in gallbladder disease in the Mexican-American population. Genet Epidemiol 1999; 16(2):191–204.
6. Reuben A. Bile formation: sites and mechanisms. Hepatology 1984; 4(suppl 5):15S-24S.
7. Smit JJ, Schinkel AH, Oude Elferink RP, Groen AK, Wagenaar E, Van Deemter L, Mol CA. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993; 75(3):451–462.
8. Smith AJ, Timmermans-Hereijgers JL, Roelofsen B, Wirtz KW, Van Blitterswijk WJ, Smit JJ, Schinkel AH. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett 1994; 354(3):263–266.
9. Reuben A. Biliary proteins. Hepatology 1984; 4(suppl 5):46S-50S.
10. Small DM, Rapo S. Source of abnormal bile in patients with cholesterol gallstones. N Engl J Med 1970; 283:53–57.
11. Admirand WH, Small DM. The physic-chemical basis of cholesterol gallstone formation in man. J Clin Invest 1968; 47: 1043–1052.
12. Carey MC, Small DM. The physical-chemistry of cholesterol solubility in bile: relationship to gallstone formation and dissolution in man. J Clin Invest 1978; 61: 998–1026.
13. Lee SP. The mechanism of mucus secretion by the gallbladder epithelium. Br J Exp Pathol 1980; 61:117–119.
14. Lee SP, Park HZ, Madani H, et al. Partial characterization of a non-micellar system of cholesterol solubilization in bile. Am J Physiol 1987; 252:G374-G383.
15. Halpern Z, Dudley MA, Kibe A, Lynn MP, Breuer AC, Holzbach RT. Rapid vesicle formation and aggregation in abnormal human biles. A time-lapse video-enhanced contrast microscopy study. Gastroenterology 1986; 90: 875–885.
16. Kibe A, Dudley MA, Halpern Z, et al. Factors affecting cholesterol monohydrate crystal nucleation time in model systems of supersaturated bile. J Lipid Res 1985; 26: 1102–1111.
17. Halpern Z, Dudley MA, Lynn MP, et al. Vesicle aggregation in model systems of bile: relation to crytal nucleation and lipid composition of the vesicular phase. J Lipid Res 1986; 27:295–306.
18. Somjen GJ, Marikovsky Y, Lelkes P, Gilat T. Cholesterol-phospholipid vesicles in human bile: an ultra structural study. Biochim Biophys Acta 1986; 879:1421.
19. Carey MC, Cohen DE. Biliary transport of cholesterol in vesicles, micelles, and liquid crystals. In: Paumgartner G, Stiehl A, Gerok W, eds. Bile Acids and the Liver. Lancaster: MTP Press, 1987:287–300.
20. Hirota I, Chijiiwa K, Noshiro J, Makayama F. Effect of chenodeoxycholate and ursodeoxycholate on nucleation time in human gallbladder bile. Gastroenterology 1992; 102:1668–1674.
21. Zhao XT, Schoenfiel LJ, Bonorris GG, Van de Velde RL, Marks JS. Increased cholesterol in vesicles is associated with rapid nucleation of human gallbladder bile. Hepatology 1994; 20:117A. Abstract.
22. Holzbach RT. Recent progress in understanding cholesterol crystal nucleation as a precursor to human gallstone formation. Hepatology 1986; 6:1403–1406.
23. Holzbach RT, Halpern Z, Dudley MA, et al. Biliary vesicle aggregation and cholesterol crystal nucleation: evidence for a coupled relationship. In: Paumgartner G, Stiehl A, Berok W, eds. Bile Acids and the Liver. Lancaster: MTP, 1987:301–316.
24. Little TE, Lee SP, Madani H, Kaler EW, Chinn K. Interconversions of lipid aggregates in rat and model bile. Am J Physiol 1991; 23:G70-G79.
25. Pattinson NR, Chapman BA. Distribution of biliary cholesterol between mixed micelles and nonmicelles in relation to fasting and feeding in humans. Gastroenterology 1986; 91:697–702.
26. Tierney S, Pitt HA, Lillemoe KD. Physiology and pathophysiology of gallbladder motility. Surg Clin North Am 1993; 73(6):1267–1290.
27. Fridhandler TM, Davison JS, Shaffer EA. Defective gallbladder contractility in the ground squirrel and prairie dog during the early stages of cholesterol gallstone formation. Gastroenterology 1983; 85(4):830–836.
28. Behar J, Lee KY, Thompson WR, Biancani P. Gallbladder contraction in patients with pigment and cholesterol stones. Gastroenterology 1989; 97(6): 1479— 1484.
29. Pomeranz IS, Shaffer EA. Abnormal gallbladder emptying in a subgroup of patients with gallstones. Gastroenterology 1985; 88(3):787–791.
30. Palasciano G, Serio G, Portincasa P, Palmieri V, Fanelli M, Velardi A, Calo' Gabrieli B. Gallbladder volume in adults, and relationship to age, sex, body mass index, and gallstones: a sonographic population study. Am J Gastroenterol 1992; 87(4):493–497.
31. Kucio C, Besser P, Jonderko K. Gallbladder motor function in obese versus lean females. Eur J Clin Nutr 1988; 42(2):121–124.
32. Marzio L, Capone F, Neri M, Mezzetti A, De Angelis C, Cuccurullo F. Gallbladder kinetics in obese patients. Effect of a regular meal and low-calorie meal. Dig Dis Sci 1988; 33(1):4–9.
33. Vezina WC, Paradis RL, Grace DM, Zimmer RA, Lamont DD, Rycroft KM, King ME. Increased volume and decreased emptying of the gallbladder in large (morbidly obese, tall normal, and muscular normal) people. Gastroenterology 1990; 98(4):1000–1007.
34. Glasbrenner B, Dominguez-Munoz JE, Nelson DK, Pieramico O, Holzwarth C, Riepl RL, Malfertheiner P. Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction [see comments]. Am J Gastroenterol 1994; 89(3):404–410.
35. Cano N, Cicero F, Ranieri F, Martin J, di-Costanzo J. Ultrasonographic study of gallbladder motility during total parental nutrition. Gastroenterology 1986; 91: 313–317.
36. Messing B, Bories C, Kuntslinger F, Benier JJ. Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology 1983; 84: 1012–1019.
37. Fisher RS, Koch E, Levin G. Effects of somatostatin on gallbladder emptying. Gastroenterology 1987; 92:88–90.
38. Johansson C, Kollberg B, Efendic S, Uvnaswallenstein K. Effects of graded dose of somatostain on gallbladder emptying and pancreatic enzyme output after oral glucose in man. Digestion 1981; 22:24–31.
39. Diamond JM. Transport of salt and water in rabbit and guinea pig gallbladder. J Gen Physiol 1964; 48:1–14.
40. Dietschy JM. Water and electrolyte movement across the wall of the everted rabbit gallbladder. Gastroenterology 1964; 47:395–408.
41. Wood JR, Svanvik J. Gall-bladder water and electrolyte transport and its regulation. Gut 1983; 24(6):579–593.
42. Shiffman ML, Sugerman HJ, Moore EW. Human gallbladder mucosal function: effect of concentration and acidification of bile on cholesterol and calcium solubility. Gastroenterology 1990; 99:1452–1459.
43. Van Erpecum KJ, Van Berge Henegouwen GP, Ko and Lee Stoelwinder B, Schmidt YMG, Willekens FLH. Bile concentration is a key factor for nucleation of cholesterol crystals and cholesterol saturation index in gallbladder bile of gallstone patients. Hepatology 1990; 11:1–6.
44. Smith BF. Human gallbladder mucin binds biliary lipids and promotes cholesterol crystal nucleation in model bile. J Lipid Res 1987; 28:1088–1097.
45. Levy PF, Smith BF, LaMont JT. Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile. Gastroenterology 1984; 87:270–275.
46. Gallinger S, Taylor RD, Harvey PRC, Petrunka CN, Strasberg SM. Effect of mucous glycoprotein on nucleation time of human bile. Gastroenterology 1985; 89:648–658.
47. Lee TJ, Smith BF. Bovine gallbladder mucin promotes cholesterol crystal nucleation from cholesterol transporting vesicles in supersaturated model bile. J Lipid Res 1989; 30:491–498.
48. Doty JE, Pitt HA, Kuchenbecker SL, Porter-Fink V, DenBestern LW. Role of gallbladder mucus in the pathogenesis of cholesterol gallstones. Am J Surg 1983; 145:54–61.
49. Lee SP. Hypersecretion of mucus glycoprotein by the gallbladder epithelium in experimental cholelithiasis. Pathology 1981; 134:199–207.
50. Lee SP, LaMont JT, Carey MC. The role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones: studies in the prairie dog. J Clin Invest 1981; 67:1712–1723.
51. LaMont JT, Turner BS, DiBenedetto D, Handin R, Schafer AI. Arachidonic acid stimulates mucin secretion in prairie dog gallbladder. Am J Physiol 1983; 245(1):G92-G98.
52. Smith BF, LaMont JT. Identification of gallbladder mucin-bilirubin complex in human cholesterol gallstone matrix. Effects of reducing agents on in vitro dissolution of matrix and intact gallstones. J Clin Invest 1985; 76:439–445.
53. Nunes DP, Afdhal NH, Offner GD. A recombinant bovine gallbladder mucin polypeptide binds biliary lipids and accelerates cholesterol crystal appearance time. Gastroenterology 1999; 116(4):936–942.
54. Murray FE, Smith BF. Non-mucin proteins in the matrix of human cholesterol gallstones. Scand J Gastroenterol 1991; 26(7):717–723.
55. Shimizu S, Sabsay B, Veis A, Ostrow JD, Dawes LG, Rege RV. A 12 kDa protein from cholesterol gallstones inhibits precipitation of calcium carbonate and is present in human bile [abstr]. Hepatology 1988; 8: 1257A.
56. Afdhal NH, Gary D, Niu N, Turner B, LaMont JT, Offner GD. Cholesterol cholelithiasis in the prairie dog: role of mucin and nonmucin glycoproteins. Hepatology 1993; 17:693–700.
57. Marks JW, Bonorris GG, Albers G, et al. The sequence Obesity and Gallbladder Disease of biliary events preceding the formation of gallstones in humans. Gastroenterology 1992; 103:566.
58. Little TE, Madani H, Lee SP, Kaler EW. Lipid vesicle fusion induced by phospholipase C activity in model bile. J Lipid Res 1993; 34(2):211–217.
59. Luk AS, Kaler EW, Lee SP. Phospholipase C-induced aggregation and fusion of cholesterol-lecithin small unilamellar vesicles. Biochemistry 1993; 32:6965–6973.
60. Groen AK, Stout JPJ, Drapers AG, et al. Cholesterol nucleation influencing activity in T-tube bile. Hepatology 1988; 8:347.
61. Groen AK, Noordam C, Drapers JA, Egbers P, Jansen PL, Tytgat GN. Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile: role in the pathogenesis of gallstone disease. Hepatology 1990; 11(4):525–533.
62. Harvey PRC, Upadhya GA, Strasberg SM. Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones. J Biol Chem 1991;266:1–8.
63. Holzbach RT, Kibe A, Thiel E, Howell JH, Marsh M, Hermann RE. Biliary proteins: unique inhibitors of cholesterol crystal nucleation in human gallbladder bile. J Clin Invest 1984; 73:35–45.
64. Kibe A, Holzbach RT, LaRusso NF, et al. Inhibition of cholesterol crystal formation by apolipoproteins in supersaturated model bile. Science 1984; 225:514–516.
65. Busch N, Lammert F, Matern S. Biliary secretory immunoglobulin A is a major constituent of the new group of cholesterol crystal-binding proteins. Gastroenterology 1998; 115(1):129–138.
66. Strasberg SM, Toth JL, Gallinger S, Harvey PRC. High protein and total lipid concentration are associated with reduced metastability of bile in an early stage of cholesterol gallstone formation. Gastroenterology 1990; 98: 739–746.
67. Whiting MJ, Watts J. Supersaturated bile from obese patients without gallstones supports cholesterol crystal growth but not nucleation. Gastroenterology 1984; 86(2):243–248.
68. Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO). The epidemiology of gallstone disease in Rome, Italy. Part I. Prevalence data in men. Hepatology 1988; 8(4):904–906.
69. Huang WS. Cholelithiasis in Singapore. Gut 1970; 11: 141.
70. Sampliner RE, Bennett PH, Comers LJ, Rose FA, Burch TA. Gallbladder disease in Pima Indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med 1970; 283:1358–1364.
71. Stitnimankarn T. The necropsy incidence of gallstones in Thailand. Am J Med Sci 1960; 240:349.
72. Einarrson K, Nilsell K, Leijd B, et al. Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. N Engl J Med 1985; 313:277.
73. Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO). The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease. Hepatology 1988; 8(4):907–913.
74. Friedman GD, Kannel WB, Dawber TR. The epidemiology of gallbladder disease: observations in the Framingham study. J Chron Dis 1966; 19:273–292.
75. Sastic JW, Glassman CI. Gallbladder disease in young women. Surg Gynecol Obstet 1982; 155(2):209–211.
76. Everson GT, McKinley C, Kern F. Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 1991; 87:237–246.
77. Henriksson P, Einarsson K, Eriksson A, Kelter U, Angelin B. Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma. J Clin Invest 1989; 84(3):811–816.
78. Kono S, Shinchi K, Ikeda N, Yanai F, Imanishi K. Prevalence of gallstone disease in relation to smoking, alcohol use, obesity, and glucose tolerance: a study of self-defense officials in Japan. Am J Epidemiol 1992; 136(7):787–794.
79. Kono S, Kochi S, Ohyama S, Wakisaka A. Gallstones, serum lipids, and glucose tolerance among male officials of self-defense forces in Japan. Dig Dis Sci 1988; 33(7):839–844.
80. Lu SN, Chang WY, Wang LY. Risk factors for gallstone among Chinese in Taiwan. J Clin Gastroenterol 1990; 12:542–546.
81. Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology 2000; 31(2):299–303.
82. Thijs C, Knipschild P, Brombacher P. Serum lipids and gallstones: a case-control study. Gastroenterology 1990; 99:843.
83. Laakso M, Suhonen M, Julkunen R, Pyorala K. Plasma insulin, serum lipids and lipoproteins in gall stone disease in non-insulin dependent diabetic subjects: a case control study. Gut 1990; 31(3): 344–347.
84. Halpern Z, Rubin M, Harach G, Grotto I, Moser A, Dvir A, Lichtenberg D. Bile and plasma lipid composition in non-obese normolipidemic subjects with and without cholesterol gallstones. Liver 1993; 13(5):246–252.
85. Kato I, Nomura A, Stemmermann GN, Chyou PH. Prospective study of clinical gallbladder disease and its association with obesity, physical activity, and other factors. Dig Dis Sci 1992; 37(5):784–790.
86. Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 1992; 55(3):652–658.
87. Moerman CJ, Smeets FW, Kromhout D. Dietary risk factors for clinically diagnosed gallstones in middle-aged men. A 25-year follow-up study (the Zutphen Study). Ann Epidemiol 1994; 4(3):248–254.
88. Attili AF, Scafato E, Marchioli R, Marfisi RM, Festi D. Diet and gallstones in Italy: the cross-sectional MICOL results. Hepatology 1998; 27(6):1492–1498.
89. Misciagna G, Centonze S, Leoci C, Guerra V, Cisternino AM, Ceo R, Trevisan M. Diet, physical activity, and gallstones—a population-based, case-control study in southern Italy. Am J Clin Nutr 1999; 69(1):120–126.
90. Leitzmann MF, Giovannucci EL, Rimm EB, Stampfer MJ, Spiegelman D, Wing AL, Willett WC. The relation of physical activity to risk for symptomatic gallstone 105, disease in men. Ann Intern Med 1998; 128:417–425.
91. Leitzmann MF, Rimm EB, Willett WC, Spiegelman D, Grodstein F, Stampfer MJ, Colditz GA. Recreational physical activity and the risk of cholecystectomy in women N Engl J Med 1999; 341(11):777–784.
92. Utter AC, Whitcomb DC, Nieman DC, Butterworth DE, Vermillion SS. Effects of exercise training on gallbladder function in an obese female population. Med Sci Sports Exerc 2000; 32(1):41–45.
93. Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Speizer FE, Willet WC. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med 1989; 321:563–569.
94. Shiffman ML, Sugerman HJ, Kellum JH, Brewer WH, Moore EW. Gallstones in patients with morbid obesity. Relationship to body weight, weight loss and gallbladder bile cholesterol solubility. Int J Obes Relat Metab Disord 1993; 17(3):153–158.
95. Acalovschi MV, Blendea D, Pascu M, Georoceanu A, Badea RI, Prelipceanu M. Risk of asymptomatic and symptomatic gallstones in moderately obese women: a longitudinal follow-up study. Am J Gastroenterol 1997; 92(1):127–131.
96. Tucker LE, Tangedahl TN, Newmark SR. Prevalence of gallstones in obese Caucasian American women. Int J Obes 1982; 6(3):247–251.
97. Thijs C, Knipschild P, Leffers P. Is gallstone disease caused by obesity or by dieting? Am J Epidemiol 1992; 135(3):274–280.
98. Palasciano G, Portincasa P, Vinciguerra V, Velardi A, Tardi S, Baldassarre G, Albano O. Gallstone prevalence and gallbladder volume in children and adolescents: an epidemiological ultrasonographic survey and relationship to body mass index. Am J Gastroenterol 1989; 84(11):1378–1382.
99. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282(16):1523–1529.
100. Petitti DB, Sidney S. Obesity and cholecystectomy among women: implications for prevention. Am J Prev Med 1988; 4(6):327–330.
101. Honore LH. Cholesterol cholelithiasis in adolescent females: its connection with obesity, parity, and oral Ko and Lee contraceptive use—a retrospective study of 31 cases. Arch Surg 1980; 115(1):62–64.
102. Weatherall R, Shaper AG. Overweight and obesity in middle-aged British men. Eur J Clin Nutr 1988; 42(3): 221–231.
103. Kodama H, Kono S, Todoroki I, Honjo S, Sakurai Y, Wakabayashi K, Nishiwaki M. Gallstone disease risk in relation to body mass index and waist-to-hip ratio in Japanese men. Int J Obes Relat Metab Disord 1999; 23(2):211–216.
104. Amaral JF, Thompson WR. Gallbladder disease in the morbidly obese. Am J Surg 1985; 149:551.
105. Calhoun R, Willbanks O. Coexistence of gallbladder disease and morbid obesity. Am J Surg 1987; 154(6): 655–658.
106. Haffner SM, Diehl AK, Stern MP, Hazuda HP. Central adiposity and gallbladder disease in Mexican Americans. Am J Epidemiol 1989; 129(3):587–595.
107. Hartz AJ, Rupley DC, Rimm AA. The association of girth measurements with disease in 32, 856 women. Am J Epidemiol 1984; 119(1):71–80.
108. Moerman CJ, Berns MP, Smeets FW, Kromhout D. Regional fat distribution as risk factor for clinically diagnosed gallstones in middle-aged men: a 25-year follow-up study (the Zutphen Study). Int J Obes Relat Metab Disord 1994; 18(6):435–439.
109. Hendel HW, Hojgaard L, Andersen T, Pedersen BH, Paloheimo LI, Rehfeld JF, Gotfredsen A. Fasting gall bladder volume and lithogenicity in relation to glucose tolerance, total and intra-abdominal fat masses in obese non-diabetic subjects. Int J Obes Relat Metab Disord 1998; 22(4):294–302.
110. Nestel PJ, Schreibman PH, Ahrens EH Jr. Cholesterol metabolism in human obesity. J Clin Invest 1973; 52(10):2389–2397.
111. Nestel PJ, Whyte HM, Goodman DS. Distribution and turnover of cholesterol in humans. J Clin Invest 1969; 48(6):982–991.
112. Miettinen TA. Cholesterol production in obesity. Circulation 1971; 44(5):842–850.
113. Stamler J. Overweight, hypertension, hypercholesterolemia, and coronary heart disease. In: Mancini M, Lewis B, Contaldo F, eds. Medical Complications of Obesity. London: Academic Press, 1979: 191–216.
114. Bennion LJ, Grundy SM. Effects of obesity and caloric intake on biliary lipid metabolism in man. J Clin Invest 1975; 56:996.
115. Madura JA, Loomis RC, Harris RA, Grosfeld J, Tompkins RK. Relationship of obesity to bile lithogenicity in man. Ann Surg 1979; 189(1):106–111.
116. Angelin B, Einarsson K, Ewerth S, Leijd B. Biliary lipid composition in obesity. Scand J Gastroenterol 1981; 16(8):1015–1019.
117. Mabee TM, Meyer P, DenBesten L, Mason EE. The mechanism of increased gallstone formation in obese human subjects. Surgery 1976; 79(4):460–468.
118. Reuben A, Maton PN, Murphy GM, et al. Biliary lipid secretion in obese and nonobese individuals with and without gallstones. Clin Sci (Colch) 1985; 69:71.
119. Salen G, Nicolau G, Shefer S, Mosbach EH. Hepatic 134, cholesterol metabolism in patients with gallstones. Gastroenterology 1975; 69(3):676–684.
120. Ahmed HA, Jazrawi RP, Goggin PM, Dormandy J, Northfield TC. Intrahepatic biliary cholesterol and phospholipid transport in humans: effect of obesity and cholesterol cholelithiasis. J Lipid Res 1995; 36(12): 2562–2573.
121. Marcus SN, Heaton KW. Deoxycholic acid and the pathogenesis of gallstones. Gut 1988; 29:522.
122. Mok HY, Von Bergmann K, Croiuse JR, Grundy SM. Bilary lipid metabolism in obesity. Effects of bile acid feeding before and during weight reduction. Gastroenterology 1979; 76(3):556–567.
123. Einarsson K, Hellstrom K, Kallner M. Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyper-lipoproteinemia. J Clin Invest 1974; 54(6):1301–1311.
124. Grundy SM, Duane WC, Adler RD, Aron JM, Metzger AL. Biliary lipid outputs in young women with cholesterol gallstones. Metabolism 1974; 23(1):67–73.
125. Caroli-Bosc FX, Pugliese P, Peten EP, Demarquay JF, Montet JC, Hastier P, Staccini P. Gallbladder volume in adults and its relationship to age, sex, body mass index, body surface area and gallstones. An epidemiologic study in a nonselected population in France. Digestion 1999; 60(4):344–348.
126. Vezina WC, Paradis RL, Grace DM, Zimmer RA, Lamont DD, Rycroft KM, King ME. Increased volume and decreased emptying of the gallbladder in large (morbidly obese, tall normal, and muscular normal) people. Gastroenterology 1990; 98:1000–1007.
127. DeWind LT, Payne JH. Intestinal bypass surgery for morbid obesity. Long-term results. JAMA 1976; 236 (20):2298–2301.
128. Delaney AG, Duerson MC, O'Leary JP. The incidence of cholelithiasis after jejunoileal bypass. Int J Obes 1980; 4(3):243–248.
129. Hocking MP, Duerson MC, O'Leary JP, Woodward ER. Jejunoileal bypass for morbid obesity. Late follow-up in 100 cases. N Engl J Med 1983; 308(17):995–999.
130. Liddle RA, Goldstein RB, Saxton J. Gallstone formation during weight-reduction dieting. Arch Intern Med 1989; 149(8):1750–1753.
131. Shiffman ML, Sugerman HJ, Kellum JM, Brewer WH, Moore EW. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 1991; 86:1000–1005.
132. Yang H, Petersen GM, Roth MP, Schoenfield LJ, Marks JW. Risk factors for gallstone formation during rapid loss of weight. Dig Dis Sci 1992; 37(6):912–918.
133. Kamrath RO, Plummer LJ, Sadur CN, Adler MA, Strader WJ, Young RL, Weinstein RL. Cholelithiasis in patients treated with a very-low-calorie diet. Am J Clin Nutr 1992; 56(suppl 1):255S-257S.
134. Shiffman ML, Sugerman HJ, Kellum HM, Brewer WH, Engle K, Moore EW. Gallstone formation following rapid weight loss. I Incidence of gallstone formation and relation to gallbladder (GB) bile lipid composition [abstr]. Gastroenterology 1990; 90:A262.
135. Worobetz LJ, Inglis FG, Shaffer EA. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol 1993; 88(10):1705–1710.
136. Syngal S, Coakley EH, Willett WC, Byers T, Williamson DF, Colditz GA. Long-term weight patterns and risk for cholecystectomy in women. Ann Intern Med 1999; 130:471–477.
137. Wise L, Stein T. The effect of jejunoileal bypass on bile composition and the formation of biliary calculi. Ann Surg 1978; 187:57–62.
138. Weinsier RL, Wilson LJ, Lee J. Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med 1995; 98(2):115–117.
139. Gebhard RL, Prigge WF, Ansel HJ. Rapid weight loss, gallbladder function and cholesterol gallstones [abstract]. Hepatology 1994; 20:267A.
140. Stone BG, Ansel HJ, Peterson FJ, Gebhard RL. Gallbladder emptying stimuli in obese and normal-weight subjects. Hepatology 1992; 15:795–798.
141. Festi D, Orsini M, Li Bassi S. Risk of gallstone formation during rapid weight loss: protective role of gallbladder motility [abstract]. Gastroenterology 1993; 102: A311.
142. Gebhard RL, Prigge WF, Ansel HJ, Schlasner L, Ketover SR, Sande D, Holtmeier K. The role of gallbladder emptying in gallstone formation during dietinduced rapid weight loss. Hepatology 1996; 24(3):544–548.
143. Andersen T. Liver and gallbladder disease before and after very-low-calorie diets. Am J Clin Nutr 1992; 56 (suppl 1):235S-239S.
144. Marks JW, Stein T, Schoenfield LJ. Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man. Dig Dis Sci 1994; 39(9): 1981–1984.
145. Takahashi T, Yamamura T, Utsonomiya J. Pathogenesis of acute cholecystitis after gastrectomy. Br J Surg 1990; 77:536–539.
146. Bolondi L, Bortolotti M, Santi V, Gaiani S, Testa S. Gallbladder sludge formation during prolonged fasting after gastrointestinal tract surgery. Gut 1985; 26:734–738.
147. Hoy MK, Heshka S, Allison DB, Grasset E, Blank R, Abin M, Heymsfield SF. Reduced risk ofliver-function test abnormalities and new gallstone formation with weight loss on 3350-KJ (800 kcal) formula diets. Am J Clin Nutr 1994; 60:249–254.
148. Reuben A, Qureshi Y, Murphy GM, Dowling RH. Ko and Lee Effect of obesity and weight reduction on biliary cholesterol saturation and the response to chenodeoxy cholic acid. Eur J Clin Invest 1985; 16:133–142.
149. Schlierf G, Schellenberg B, Stiehl A, Czygan P, Oster P. Biliary cholesterol saturation and weight reduction— effects of fasting and low calorie diet. Digestion 1981; 21: 44–49.
150. Soorensen TIA, Brussgaard A, Pederson LR, Krag E. Lithogenic index of bile after jejunoileal bypass operation for obesity. Scand J Gastroenterol 1977; 12:449–451.
151. Shiffman ML, Sugerman JH, Kellum JM, et al. Changes in gallbladder bile composition following gallstone formation and weight reduction. Gastroenterology 1992; 103:214.
152. Shiffman ML, Shamburek RD, Schwartz CC, Suger man HJ, Kellum JM, Moore EW. Gallbladder mucin, arachidonic acid, and bile lipids in patients who develop gallstones during weight reduction. Gastroenterology 1993; 105(4):1200–1208.
153. Freeman JB, Meyer PD, Printen KJ, Mason EE, DenBesten L. Analysis of gallbladder bile in morbid obesity. Am J Surg 1975; 129:163–166.
154. Inoue K, Fuchigama A, Higashide S, Sumi S, Kogire M, Suzuki T, Tobe T. Gallbladder sludge and stone formation in relation to contractile function after gastrectomy. Ann Surg 1992; 215:19–26.
155. Festi D, Colecchia A, Orsini M, Sangermano A, Sottili S, Simoni P, Mazzella G. Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well). Int J Obes Relat Metab Disord 1998; 22(6):592–600.
156. Danzinger RG, Hofmann AF, Thistle JL, et al. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis. J Clin Invest 1972; 52:2809.
157. Mazzella G, Bazzoli F, Festi D, Ronchi M, Aldini R, Roda A, Grigolo B. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction. Gastroenterology 1991; 101(2):490–496.
158. Iser JH, Maton PN, Murphy GM, Dowling RH. Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones. BMJ 1978; 1(6126): 1509–1512.
159. Maton PN, Murphy GM, Dowling RH. Lack of response to chenodeoxycholic acid in obese and nonobese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid. Gut 1980; 21 (12): 1082–1086.
160. Whiting MJ, Hall JC, Iannos J, Roberts HG, Watts JM. The cholesterol saturation of bile and its reduction by chenodeoxycholic acid in massively obese patients. Int J Obes 1984; 8(6): 681–688.
161. Zuin M, Petroni ML, Grandinetti G, Crosignani A, Bertolini E, Battezzati PM, Podda M. Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones. Scand J Gastroenterol 1991; 26(3):257–262.
162. Okamoto S, Nakano K, Kosahara K, Kishinaka M, Oda H, Ichimiya H, Chijiiwa K. Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones. J Gastroenterol 1994; 29(1):47–55.
163. Marks JW, Bonorris GG, Schoenfield LJ. Effects of ursodiol or ibuprofen on contraction of gallbladder and bile among obese patients during weight loss. Dig Dis Sci 1996; 41(2):242–249.
164. Shiffman ML, Kaplan GD, Brinkman-Kaplan V, Vickers FF. Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program. Ann Intern Med 1995; 122:899–905.
165. Sugerman HJ, Brewer WH, Shiffman ML, Brolin RE, Fobi MA, Linner JH, MacDonald KG. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg 1995; 169(1):91–96.
166. Shoheiber O, Biskupiak JE, Nash DB. Estimation of the cost savings resulting from the use of ursodiol for the prevention of gallstones in obese patients undergoing rapid weight reduction. Int J Obes Relat Metab Disord 1997; 21(11):1038–1045.
167. Broomfield PH, Chopra R, Scheinbaum RC, Bonorris GG, Silverman A, Schoenfield LJ, Marks JW. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med 1988; 319:567–572.
168. Yamada T, ed. Atlas of Gastroenterology. 2d ed. Philadelphia: Lippincott Williams and Wilkins, 1999.